酷派集團(02369.HK)中期淨虧損2.38億港元 虧損同比擴大261%
格隆匯8月24日丨酷派集團(02369.HK)發佈公吿,截至2021年6月30日止6個月,公司來自持續經營業務的收益3.2億港元,同比減少17.1%;公司擁有人應占淨虧損2.38億港元,虧損同比擴大261%;每股虧損3.11港仙。
儘管集團宣佈於2020年底迴歸中國市場,公司於2021年上半年主要處於資源整合、設計、研發及生產新產品等需時檢驗的階段。本年度打造的第一款新品酷派COOL20手機已於2021年5月25日發佈。此外,由於前端零售交付系統能力仍然不足,產品的銷量並無顯著提升,因此有關產品仍未能對集團2021年上半年的財務表現作出重大貢獻。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.